X-Health.show - meet the future of healthcare
The X-Health.show brings to you brilliant minds behind programming living cells, tech that detects pre-term delivery in seconds, brain-computer interface or apps that employ AI to match you, your disease with the best treatment.
For the eXtra Health of the future.
You’ll meet visionaries from Switzerland who push the boundaries of healthcare.
Engineers who teamed up with doctors, scientists turned CEOs, doctors programming AI-powered apps, researchers who abandoned university labs to improve your health.
You’ll hear stories of promising startups founders and successful serial entrepreneurs.
Patients who imagine a better way.
You’ll
learn about new disease treatments
understand how AI-driven health tech can improve your life
grasp the way founders innovate
or even, get inspired to jumpstart innovation at your company.
Luckily, the X-Health.show is based in Switzerland, the most innovative country in the world according to World Intellectual Property Organization. For the 12th consecutive year. No wonder when the abundance of funds for innovation meets the ability to commercialize the discoveries.
With notable research institutions situated nearby top pharmaceutical companies, there’s more to expect. More medical innovations, break-through femtech, life changing biotech, developments in digital health, genetic engineering, and wearables, such as smart ring, blood pressure measurement on your wrist or ECG in your pyjama.
Follow the show to meet these amazing innovators.
X-Health.show - meet the future of healthcare
Treating Cancer with Bacteria: Dr. Ana Montalban-Arques, Recolony
A specific strain of bacteria might help prevent and even treat colorectal cancer. The studies in animals show potential in treating other cancers, too.
You’ll hear about
- how many bacteria inhabit a human and how much do they weigh (I bet you underestimate their weight)
- what is a dysbiotic gut microbiome
- the gut microbiome and its influence on colorectal cancer
- studies of specific strains of bacteria that show reducing cancer in mice
- what is the potential of life biotherapeutic products
My guest today is Dr. Ana Montalban-Arques, the CEO of Recolony. Trained in molecular biology and biotechnology she researched host-microbe interactions in the gut.
Recolony is a Swiss startup, a spin-off from the University of Zurich. They aim to develop a bacteria-based oral therapy to treat and prevent colorectal cancer. No chemotherapy, no side effects – oral administration at home. Please note, their treatment is in the pre-clinical phase and it means it is not yet available for patients.
You may find out more about them at
https://www.recolony.ch/
If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.
